Sarah Psutka

19PUBLICATIONS
107CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyRadiation therapyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 29, 2026
Patient-reported outcomes as non-muscle-invasive bladder cancer clinical trial endpoints.

|Sep 16, 2026
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes.

|Aug 27, 2026
Subcutaneous Fat Is Associated with Improved Survival in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: Dissecting the Obesity Paradox.

|Jul 08, 2026
The impact of cachexia and sarcopenia in bladder cancer.

|Mar 28, 2026
Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC).

Michael Staehler, Iulia Blajan, Can Aydogdu

|Dec 03, 2025
Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen

Pageof 4

Frequent Collaborators

4 joint publications

Shilpa Gupta

3 joint publications

Petros Grivas

3 joint publications

Laura Bukavina

3 joint publications

Ashish M Kamat